This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-preview: Archive
Countdown to Bright Horizons (BFAM) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Bright Horizons (BFAM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
BFAMPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Microchip Tech (MCHP) Q2 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Microchip Tech (MCHP) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
MCHPPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Pan American Silver (PAAS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of Pan American Silver (PAAS) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
PAASNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Voya (VOYA) Q3: Wall Street Projections for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Voya (VOYA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
VOYANegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for Globus Medical (GMED) Q3 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
GMEDPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Seeking Clues to ADM (ADM) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for ADM (ADM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
ADMNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Stay Ahead of the Game With Cummins (CMI) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Cummins (CMI) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
CMINegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q3 Potential of Henry Schein (HSIC): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Henry Schein (HSIC) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
HSICPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unlocking Q3 Potential of Expeditors International (EXPD): Exploring Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Expeditors International (EXPD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
EXPDPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Gear Up for Vornado (VNO) Q3 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Vornado (VNO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
VNONegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Westlake (WLK) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Westlake (WLK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
WLKPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Insights Into Broadridge Financial (BR) Q1: Wall Street Projections for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Broadridge Financial (BR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2024.
BRNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Analyst Projections for Key Metrics Reveal About DuPont de Nemours (DD) Q3 Earnings
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for DuPont de Nemours (DD), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
DDNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Exploring Analyst Estimates for Restaurant Brands (QSR) Q3 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Get a deeper insight into the potential performance of Restaurant Brands (QSR) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
QSRPositive Net Change
earnings earnings-estimates earnings-expectations earnings-preview
Unveiling International Flavors (IFF) Q3 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of International Flavors (IFF) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
IFFNegative Net Change
earnings earnings-estimates earnings-expectations earnings-preview
What Should You Do With BRK.B Stock Ahead of Q3 Earnings?
by Tanuka De
Berkshire's insurance business is likely to be affected by catastrophe loss in Q3, though better performance of its other businesses should offer respite.
BRK.BPositive Net Change ALLNegative Net Change PGRNegative Net Change
earnings-preview insurance
Should SharkNinja Stock be Part of Your Portfolio Ahead of Q3 Earnings?
by Ankita Gupta
Does SN's innovative and differentiated product offerings stand out as a top investment choice before third-quarter earnings?
WHRNegative Net Change HELEPositive Net Change SNNegative Net Change CRCTNegative Net Change
consumer-discretionary earnings-preview
Earnings Preview: TripAdvisor (TRIP) Q3 Earnings Expected to Decline
by Zacks Equity Research
TripAdvisor (TRIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TRIPPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
SolarEdge Technologies (SEDG) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
SolarEdge (SEDG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SEDGPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Super Micro Computer (SMCI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Super Micro (SMCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SMCINegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Schneider National (SNDR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Schneider National (SNDR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SNDRPositive Net Change EXPDPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TNDMPositive Net Change MASIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Perrigo (PRGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRGOPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Qualcomm (QCOM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Qualcomm (QCOM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
QCOMPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
RCUSPositive Net Change DNLIPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate